IFP Advisors’s Cardiff Oncology CRDF Stock Holding History

IFP Advisors’s Portfolio CRDF Stock Details CRDF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$8	Buy	+5	New	+$10	﹤0.01%	4977
2025 Q2	–	Hold	0	–	–	–	4730
2019 Q1	–	Sell	-7	Closed	–	–	2548
2018 Q4	$0	Sell	7 -28	-80%	-$128	﹤0.01%	3577
2018 Q3	$0	Hold	35	–	–	﹤0.01%	3855
2018 Q2	$0	Hold	35	–	–	﹤0.01%	3901
2018 Q1	$1K	Hold	35	–	–	﹤0.01%	3612
2017 Q4	$1K	Sell	35 -7	-17%	-$310	﹤0.01%	3663
2017 Q3	$2K	Hold	42	–	–	﹤0.01%	3728
2017 Q2	$4K	Hold	42	–	–	﹤0.01%	3488
2017 Q1	$3K	Sell	42 -41	-49%	-$5.57K	﹤0.01%	3500
2016 Q4	$13K	Sell	83 -105	-56%	-$24.5K	﹤0.01%	2738
2016 Q3	$61K	Buy	188 +32	+21%	+$11.7K	﹤0.01%	1685
2016 Q2	$51K	Buy	+156	New	+$53.7K	﹤0.01%	1748
2016 Q1	–	Sell	-7	Closed	-$3K	–	2554
2015 Q4	$3K	Buy	+7	New	+$2.74K	﹤0.01%	3164

Other funds holding CRDF

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LCM

Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

FLPIM

F.L. Putnam Investment Management Lynnfield, Massachusetts $6.71B AUM 23.99% 1-Year Est. Return

IFP Advisors's CRDF Position: Q1 2026 in Review

IFP Advisors opened a new position in Cardiff Oncology (CRDF) in Q1 2026: 5 shares worth $8. The stake represents ﹤0.01% of the portfolio and ranks #4977 among its holdings. This is a return to the name: IFP Advisors previously reported a position in CRDF as recently as Q4 2018.

IFP Advisors first reported a position in CRDF in Q4 2015 and has held it in 13 quarters since. The position peaked at $61K in Q3 2016. 116 funds tracked by Wall St. Rank hold CRDF as of Q1 2026.

IFP Advisors held 5 shares of Cardiff Oncology worth $8 as of Q1 2026.
Cardiff Oncology was a new IFP Advisors position in Q1 2026.
Cardiff Oncology made up ﹤0.01% of IFP Advisors's portfolio in Q1 2026, its #4977 holding.
IFP Advisors first reported a position in Cardiff Oncology in Q4 2015 and has held it in 13 quarters since.
IFP Advisors's Cardiff Oncology position peaked at $61K in Q3 2016.
116 funds tracked by Wall St. Rank held Cardiff Oncology as of Q1 2026.

Based on IFP Advisors's 13F filing for Q1 2026, filed 13 Apr 2026.